JAK2V617F mutation and associated chromosomal alterations in primary and secondary myelofibrosis and post-HCT outcomes.
Study #: IB17-03b
Study Status: Published
JAK2 V617F mutation and associated chromosomal alterations in primary and secondary myelofibrosis and post-HCT outcomes.
Rafati M, Brown DW, Zhou W, Jones K, Luo W, St Martin A, Wang Y, He M, Spellman SR, Wang T, Deeg HJ, Gupta V, Lee SJ, Bolon YT, Chanock SJ, Machiela MJ, Saber W, Gadalla SM.
Blood Advances. 2023, Dec 26: 7(24): 7(24):7506-7515. doi: 10.1182/bloodadvances.2023010882. Epub 2023, Oct 27. PMCID:PMC10758737.
PMID: 38011490
Abstract